{"product_id":"2940012054159","title":"Medifocus Guidebook on: Multiple Myeloma","description":"The MediFocus Guidebook on Multiple Myeloma is the most comprehensive, up-to-date source of information available. You will get answers to your questions, including risk factors of Multiple Myeloma, standard and alternative treatment options, leading doctors, hospitals and medical centers that specialize in Multiple Myeloma, results of the latest clinical trials, support groups and additional resources, and promising new treatments on the horizon. This one of a kind Guidebook offers answers to your critical health questions including the latest treatments, clinical trials, and expert research; high quality, professional level information you can trust and understand culled from the latest peer-reviewed journals; and a unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.\u003cbr\u003e\u003cbr\u003eMultiple myeloma (MM) is one of several cancers categorized as \"plasma cell dyscrasias.\" They account for 10% of all blood system malignancies.\u003cbr\u003e\u003cbr\u003eThe immune system has several types of cells that work together to fight infection and disease. Lymphocytes are the main immune system cell types. When B-cell lymphocytes respond to an infection, they mature and change into plasma cells, which produce and release proteins called immunoglobulins (antibodies) that attack and help kill disease-causing germs.\u003cbr\u003e\u003cbr\u003eBut, when these plasma cells grow out of control, they can produce tumors that in several sites, especially in bone marrow (plasmacytomas). When these tumors grow in multiple sites, they are called multiple myeloma (MM). This cancer can produce various skeletal, blood system and kidney symptoms and is most often diagnosed during an evaluation for unrelated problems, although it can present with bone pain or a fracture.\u003cbr\u003e\u003cbr\u003eMM is the most common primary bone cancer in adults (generally in those older than 50) with an annual U.S. incidence of 3 to 4 cases per 100,000 people. It occurs with greatest frequency in African-Americans and is very rare among Asians.\u003cbr\u003e\u003cbr\u003eOral or intravenous chemotherapy is the standard treatment to destroy or control myeloma cells. Radiation may also be used. The choice of regimen depends on the patient's age and kidney function, and the stage of the disease. Treatment focuses on achieving and maintaining remission and on preventing complications.\u003cbr\u003e\u003cbr\u003eLearn more by ordering your MediFocus Guidebook on Multiple Myeloma, the most comprehensive, up-to-date source of information available. You will get answers to your questions, including:\u003cbr\u003e\u003cbr\u003e    * What are the risk factors of Multiple Myeloma?\u003cbr\u003e    * What standard and alternative treatment options are available?\u003cbr\u003e    * Where are the leading doctors, hospitals and medical centers that specialize in Multiple Myeloma research and treatment?\u003cbr\u003e    * What are the results of the latest clinical trials?\u003cbr\u003e    * Where are the support groups and additional resources in my area?\u003cbr\u003e    * What are the promising new treatments on the horizon?\u003cbr\u003e\u003cbr\u003eYou won't find this combination of information anywhere else. Your health matters. Don't leave it to chance. Arm yourself with the most comprehensive, up-to-date research available by ordering your MediFocus Guidebook today.\u003cbr\u003e\u003cbr\u003eThis Guidebook was updated on September 14, 2010.","brand":"Medifocus.com","offers":[{"title":"Default Title","offer_id":47073238122736,"sku":"2940012054159","price":19.5,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0737\/7593\/9824\/files\/2940012054159_p0.jpg?v=1763552301","url":"https:\/\/shop-qa.barnesandnoble.com\/products\/2940012054159","provider":"Barnes \u0026 Noble (DEV)","version":"1.0","type":"link"}